Sangamo Therapeutics (SGMOQ) Other Non Operating Income (2024 - 2025)
Sangamo Therapeutics (SGMOQ) posted quarterly Other Non Operating Income of -$21000.0 for Q4 2025, down 101.12% year-over-year from $1.9 million in Q4 2024, and down 119.63% quarter-over-quarter from $107000.0 in Q3 2025.
Sangamo Therapeutics (SGMOQ) Other Non Operating Income (2024 - 2025) Analysis & Trends
Sangamo Therapeutics' Other Non Operating Income history runs 2 years deep, the most recent figure standing at -$21000.0 for Q4 2025.
- In Q4 2025, Other Non Operating Income fell 101.12% year-over-year to -$21000.0; the TTM figure through Dec 2025 stood at -$3.6 million (down 181.95% YoY), while the FY2025 annual figure was -$3.6 million, down 181.95% from the prior year.
- Other Non Operating Income for Q4 2025 stood at -$21000.0, down from $107000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $2.1 million in Q1 2024, with the low at -$2.5 million in Q2 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -21,000.00 |
| Sep 30, 2025 | 107,000.00 |
| Jun 30, 2025 | -2.49 Mn |
| Mar 31, 2025 | -1.16 Mn |
| Dec 31, 2024 | 1.87 Mn |
| Sep 30, 2024 | -221,000.00 |
| Jun 30, 2024 | 614,000.00 |
| Mar 31, 2024 | 2.08 Mn |